Monoclonal antibodies can be defined as an antibody produced by a single clone of cells; these antibodies can be produced in large quantities in the laboratory. They can be used to carry drugs, toxins, or radioactive substances straight to cancer cells. Monoclonal antibodies have been showing promising results in the management of chronic diseases such as cancers and rheumatoid arthritis.
European market for Protein A Resins is driven by factors such as growing demand for biosimilars and increasing investments into the research and development of biosimilar products while increasing awareness about alternate methods to purify monoclonal antibodies is anticipated to hamper the growth of Protein A Resins market. Another major factor restraining the growth of Protein A resins market is high cost of these products
Europe Protein A Resins Market was worth $ 95.43 million in 2018 and estimated to be growing at a CAGR of 7.8%, to reach $138.92 million by 2023. The market is showing evident potential in the mentioned forecast period. Increasing research and development activities on monoclonal antibodies is expected to drive sales of Protein A resins in the future.
European market for Protein A resin is segmented by product type, application, matrix type and end user. Based on product the market is further segmented into Natural Protein A Resin and Recombinant Protein A Resin. Recombinant Protein A segment is estimated to be the fastest growing product segment. By application protein A Resin market is analyzed as Immuno precipitation and Antibody Purification. Immuno precipitation segment is estimated to be the fastest growing. Based on Matrix type Europe Protein A Resin market is segmented into Glass or Silica, Agarose and Organic Polymer. Among the matrix type agarose accounts for the largest share and is estimated to continue its strong share during the forecast period. By end user the market is segmented into Biopharmaceutical Manufacturers, Clinical Research Laboratories and Academic Institutions
Geographically Europe Protein A resin market is analysed under various regions namely United Kingdom, Germany, Italy, Spain and France. Europe is the second largest market for Protein A resin accounting for a share of approximately XX%. Within Europe, United Kingdom is largest market for Protein A resins where as Germany is estimated to be the fastest growing region
Some of the major companies covered in the report are GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore and Expedeon Ltd.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Natural Protein A Resin
5.1.2 Recombinant Protein A Resin
5.2 By Application
5.2.1 Immunoprecipitation
5.2.2 Antibody Purification
5.3 By End Users
5.3.1 Biopharmaceutical Manufacturers
5.3.2 Clinical Research Laboratories
5.3.3 Academic Institutes
5.4 By Matrix Type
5.4.1 Glass or Silica
5.4.2 Agarose
5.4.3 Organic Polymer
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Thermo Fisher Scientific
8.3 Repligen
8.4 Tosoh Bioscience
8.5 EMD Millipore
8.6 Novasep
8.7 GenScript
8.8 Expedeon Ltd
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
